4//SEC Filing
Smith Devin Whittemore 4
Accession 0000905148-25-001094
CIK 0001865494other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:13 PM ET
Size
5.4 KB
Accession
0000905148-25-001094
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith Devin Whittemore
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2025-04-02+140,000→ 140,000 totalExercise: $1.07Exp: 2035-04-02→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001747818
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:13 PM ET
- Size
- 5.4 KB